Patients presenting to emergency departments with opioid overdose have high rates of hepatitis C virus (HCV) infection, ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Efficacy based on baseline viral load categories was comparable between both treatment ... “We know taking fewer medicines is ...

The sex of people living with HIV-1 infection, schistosome infection, or both, is a fundamental determinant of their clinical ...

Code Pharma today announced positive eight-week results for human immunodeficiency virus (HIV)-drug Gammora®, showing ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

A pop-up sexual health clinic has seen an increase in the number of new people coming forward to get tested for HIV. The ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...